Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates

Listen Now

Topics Covered

• Overview of Diffuse Large B-Cell Lymphoma
• Staging and Grading
• Current Standard of Care
• Treatment Options for Resistant Disease
• New and Emerging Treatment Approaches
• The Role of Clinical Trials
• How Research Contributes to Treatment Choices
• Tips to Manage Treatment Side Effects, Symptoms, Discomfort and Pain
• The Increasing Role of Telehealth/Telemedicine Appointments
• Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions and Discussion of OpenNotes
• Questions to Ask Our Panel of Experts

Our Panel of Experts

Catherine S M Diefenbach, MD

Associate Professor of Medicine, Translational Director of Hematology, Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-designated Comprehensive Cancer Center, NYU Langone Health

Erin Mulvey, MD

Assistant Professor of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine

Samuel Yamshon, MD

Assistant Professor of Medicine, Bone Marrow Transplant and Cellular Therapy Program, Lymphoma Program, Weill Cornell Medicine, Division of Hematology & Medical Oncology

Belita Cowan, MA

President, Lymphoma Foundation of America^®

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on February 22, 2024.